Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Contrarius Global Equity Fund recorded exceptional performance for the quarter ending September 30, 2025, returning 30.9% net of fees compared to 7.3% for the benchmark MSCI World Index. The letter addresses...
— Waystone Management Company (IE) Limited
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($55/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Intellia Therapeutics
No other institutional pitches found for this ticker yet.